(Updates dateline, adds AbbVie-Iambic deal) Sept 21 (Reuters) – Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development, betting on new
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
* H200 chips are among Nvidia's most advanced AI processors * Caught in trade tension…
By Sophie Kiderlin, Canan Sevgili and Stefano Rebaudo LONDON, Nov 6 (Reuters) - Uncertainty over…
By Heejin Kim, Kyu-seok Shim, Maggie Grether and Brenda Goh SEOUL, Nov 6 (Reuters) -…
KTCS Corp: * KTCS CORP: Q3 OPERATING PROFIT 12.4 BILLION WON, UP 35.5% FROM YEAR…
Hankook Tire & Technology Co Ltd: * HANKOOK TIRE & TECHNOLOGY: Q3 OPERATING PROFIT 599…
By Sophie Kiderlin, Canan Sevgili and Stefano Rebaudo LONDON, Nov 6 (Reuters) - Uncertainty over…